Flora Growth Signs Definitive Agreement to Acquire Vessel Brand for $30 Million

Spread the love

<![CDATA[

  • Vessel, a leader in the luxury cannabis consumer technology market, will diversify Flora’s premium brand portfolio.
  • Pending acquisition represents opportunity to fast-forward Flora’s penetration into U.S. and Canadian cannabis markets by acquiring a rapidly expanding, industry-leading company with strong revenue growth.
  • Vessel leadership to integrate with Flora’s core management team and leverage its extensive brand building, marketing and sales experience to amplify and accelerate growth across Flora’s global portfolio.

MIAMI and TORONTO, Nov. 3, 2021 – PRESS RELEASE – Flora Growth Corp., a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced it has entered into a definitive agreement in respect of the previously announced acquisition of 100% of Vessel Brand Inc. As set forth below, upon the closing of the transaction, Flora will acquire Vessel for aggregate consideration of U.S. $30 million, consisting of a combination of cash and the issuance of Flora common shares.

“The Flora team has been working diligently to execute on our various business initiatives and the signing of this agreement represents another significant step forward for the company in 2021,” Flora Growth President and CEO Luis Merchan said. “We are incredibly excited to have reached an agreement to add Vessel to the Flora portfolio. Not only does Vessel have an exceptional product line with strong revenue growth, but its leadership team is second to none. Integration plans with the Vessel team are already well advanced and we expect step-change improvements to the marketing and sales strategies for our core consumer brands like Stardog and Mind Naturals, as well as new brand development in support of our global growth initiatives.”

Vessel will bring a proven go-to-market strategy for direct-to-consumer sales for U.S. and international cannabis markets. Vessel has also established relationships with U.S. multistate operators and Canadian LP’s who seek access to Vessel’s premium technology offering through its white labeling business. Headquartered in Carlsbad, Calif., Vessel will serve as a key component of Flora’s North American cannabis strategy across its entire product portfolio.

Vessel launched in 2018 with a singular focus—create a more thoughtful consumer experience at all touchpoints. With significant revenue growth year-over-year, Vessel finds continued success by bringing to market innovative products and experiences that elevate consumer expectations. It has a unique lineup of high-end, dry-herb accessories and vape pen batteries, bespoke product programs for brands, and decades of go-to-market experience. These high-margin products, along with its development pipeline, are expected to drive incremental revenue and market share growth in new and existing categories.

The acquisition of Vessel is also expected to strengthen Flora’s executive leadership team with the addition of the Vessel team’s experienced cannabis, sales, marketing, design and production professionals, including founder and CEO James Choe, Chief Financial Officer Garrett Potter, VP of Marketing Jessie Casner and VP of Performance Jason Choe.

“As Vessel, and as brand builders in nearly every sector, our promise has been to create unparalleled experiences—we are looking forward to continuing to deliver on that promise with Flora,” Choe said. “Flora is positioned to be a global leader in plant-based health and wellness by redefining the traditional narrative of a cannabis company. With unrivaled economies in the supply chain, a diverse brand portfolio roadmap, and most importantly a team built to meet the challenges of the industry, we see significant opportunities ahead.”

About the Transaction

Pursuant to the terms of the definitive agreement among Flora, Vessel and certain related third parties, upon the closing of the transaction (the “Closing”), Vessel will merge into a wholly owned subsidiary of Flora, and Flora will acquire 100% of the equity interests of Vessel for consideration consisting of $8 million in cash and 4,557,318 privately issued Flora common shares.

Certain shareholders of Vessel who will receive in excess of a majority of the Flora common shares issued as part of the transaction consideration will be required to enter into lock-up agreements restricting the transfer of such common shares for a period of six months from the Closing. The Closing is subject to customary closing conditions, including the accuracy of representations and warranties and the fulfillment of certain covenants of the parties. It is anticipated that the Closing will take place in mid-November.

]]>
Source: One

Schaka

Related Posts

Flora Growth Enters Cannabis Beverage Market Through Licensing Agreement With Tonino Lamborghini

Unionized Budtender Gets Job Back

Superlatives in news articles reporting non-FDA approved indications for use of cannabis and cannabis products with a focus on psychiatric disorders: a cross-sectional analysis

Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series

Signez la pétition !!!

 

846 signatures

Pétition ASBL Cannabis Belgique

Pourquoi une pétition ?

Nous sommes des personnes qui en avons assez de devoir aller dans la rue et avoir affaire à des réseaux criminels sans savoir où cela va nous conduire par après.

Nous sommes des personnes ayant des maladies, qui pour certaines sont rares, et utilisant pour médication le cannabis sous diverses formes (CBD,THC,THCv,CBDa,,,) sous l'accord de notre médecin.

Nous sommes des personnes responsables et honnêtes qui avons une vie épanouie et sans problèmes de vie ou sociaux.

Nous avons également une passion pour la plante de cannabis en elle-même et la cultiver est notre bonheur. De plus, nous pouvons nous soigner avec notre médication sans avoir peur des produits ou autres additifs contenus dans une plante que l'on peut trouver autre part.

Nous souhaitons pouvoir avoir notre médicament dans les normes de la santé publique, car un cannabis sain aide à réduire les frais de santé parfois conséquents pour la collectivité et le malade lui-même.

Nous sommes également des personnes responsables avec un rôle dans la société qui en avons assez d’être considérés comme des « hippies ou autres drogués », nous avons juste choisi notre médication et celle-ci a apporté les preuves de son efficacité dans le monde.

Nous connaissons déjà les produits dérivés comme le CBD et le THC que nous maîtrisons pour nous aider dans notre maladie « Je précise que nous ne sommes pas médecin et que nous nous basons sur 20 ans d’expérience médicale du cannabis des membres de notre ASBL et l'avis du médecin de famille ».

Nous désirons simplement ne plus nous cacher, et pouvoir aider les autres personnes le souhaitant.

Nous somme soucieux des ados et de la prévention à leur égard. Effectivement, nous sommes les acteurs parfaits pour répondre aux questions qu’ils se posent vu notre expérience cannabique et, de plus, nous pourrons leur expliquer les risques qu’ils encourent en achetant du cannabis dans la rue.

Le projet complet peut être demandé via mail " info@mcb.care " et sur le site internet : " http://mcb.care "

@ASBL McB

**votre signature**

Partagez avec vos amis

Articles récents

Catégories